Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
PHIO PHARMACEUTICALS CORP.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
phiopharma.comAI Executive Summary
AI-powered analysis of 8-K filing content
Phio Pharmaceuticals held its 2026 Annual Meeting on September 28, 2026, where stockholders approved an amendment to the 2020 Long Term Incentive Plan, increasing available shares by 1.5 million to a total of 2.45 million shares. This strategic move enhances the company's ability to incentivize and retain key personnel.
Key Takeaways
Stockholders approved a 1,500,000 share increase to the 2020 Long Term Incentive Plan, effective immediately
Total shares available under the plan increased from 952,017 to 2,452,017 shares
2 more takeaways
Filing Overview
What This Means
PHIO PHARMACEUTICALS CORP. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.